Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
11/2001
11/13/2001US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/08/2001WO2001083429A1 Aniline derivatives
11/08/2001WO2001083427A1 PPARη MODULATORS
11/08/2001US20010039344 Antidiabetic agents
11/08/2001DE10019755A1 New cyclic carboxylic acids are integrin antagonists, useful for treating inflammatory diseases, autoimmune and immune disorders, e.g. atherosclerosis, asthma and diabetes
11/08/2001CA2407587A1 Ppar.gamma. modulators
11/07/2001EP0918809B1 Process for producing polyisocyanates containing biuret groups from (cyclo) aliphatic diisocyanates
11/07/2001EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/06/2001US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001US6313174 Aminobenzophenones as inhibitors of interleukin and TNF
11/06/2001US6313071 Phenylacetylene derivatives and agricultural/horticultural fungicides
11/04/2001CA2346149A1 Photo-reactive benzocyclobutenones and polymers therefrom for self-photocuring, photo-crosslinking and photopatterning without catalysts
11/01/2001WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
10/2001
10/31/2001EP1149066A1 Method of preparing alkylated salicylamides
10/31/2001CN1320130A Polymerization of olefins
10/31/2001CN1319588A Fluorodiol and application thereof
10/30/2001US6310178 Ureins derived from α, ω-diamino acids and process for their preparation
10/30/2001US6310078 Substituted amino acids as erythropoietin mimetics
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents
10/25/2001US20010034413 Polyurethanes
10/25/2001US20010034371 Antidiabetic agents
10/25/2001US20010034342 Brain disorders, antiischeic agents
10/24/2001EP1148048A2 Polyaromatic antiviral compositions
10/23/2001US6307001 Amine, ether or sulfide groups with vinyl ethers
10/23/2001US6306884 Benzamidine derivatives and their use as anti-coagulants
10/23/2001US6306840 Cell adhesion inhibitors
10/18/2001WO2001077077A1 Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
10/18/2001US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001US20010031865 Herbicides
10/17/2001EP1144476A1 Coating agents which can be hardened by the addition of isocyanate groups as well as by the radiation-induced addition of activated c-c double covalent bonds
10/17/2001EP1144366A2 Use of androgen receptor suppressors
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001CN1073081C Naphthol derivatives and process for producing same
10/16/2001CA2215596C Process for preparing granular urea
10/16/2001CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001WO2001074761A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
10/11/2001CA2404628A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
10/10/2001EP1142868A1 Amide derivatives
10/10/2001EP1142867A2 Cell adhesion inhibitors
10/10/2001EP1141147A1 Process for synthesis of allophanate compounds and compositions including the product thereof
10/10/2001EP1140840A1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
10/10/2001EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140745A1 Colchinol derivatives as vascular damaging agents
10/10/2001CN1316990A Methoximinophenylacetic acid amides
10/04/2001WO2001021577A3 Melanin concentrating hormone antagonist
10/04/2001US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma
10/04/2001EP1137632A1 Thiourea inhibitors of herpes viruses
10/03/2001CN1315938A Novel color-developing compound and recording material
10/03/2001CN1315936A Compounds and compositions for delivering active agents
10/03/2001CN1072217C Process for producing 2-substituted-3,4-condensed heterocyclic benzoic acid
10/02/2001US6297276 Substituted urea and isothiourea derivatives as no synthase inhibitors
10/02/2001US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure
09/2001
09/27/2001WO2001070684A2 Peptidomimetic ligands for cellular receptors and ion channels
09/27/2001WO2001070675A2 Inhibitors of histone deacetylase
09/27/2001US20010025128 Chain transfer agents
09/27/2001CA2404002A1 Inhibitors of histone deacetylase
09/26/2001EP1135366A1 Method of introducing melamine off-gases into a urea plant
09/26/2001EP0844236B1 Process for producing carbamoylmethylurea derivatives
09/26/2001CN1071742C Improved process for synthesis of urea and equipoment thereof
09/25/2001US6294708 Alpha-methylstyrene dimer derivatives
09/25/2001US6294695 Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
09/25/2001US6294694 Inhibit endotoxic shock, systemic inflammatory response syndrome, proliferation of cancer cells, invasion of basement membranes by cancer cells
09/20/2001WO2000071506A9 Naphthalene ureas as glucose uptake enhancers
09/18/2001US6291520 Hydroxamic acid and N-hydroxyurea derivatives and their use
09/18/2001CA2026890C Quinoline derivatives, their production and use
09/13/2001WO2001066515A1 Novel color former and recording material
09/13/2001WO2001028498A3 Retro-anandamides, high affinity and stability cannabinoid receptor ligands
09/13/2001CA2399054A1 Novel color-producing composition and recording material
09/12/2001EP1132378A2 Fluorine-containing diols and use thereof
09/12/2001EP1131319A2 3- benz(ox/thi)azol-7-yl -1h-pyrimidine-2,4-diones
09/12/2001CN1312795A New 3-aryl propionic acid derivatives and analogs
09/11/2001US6288234 Fluorinated heterocyclic amido amine compounds as drugs
09/07/2001WO2001019780A3 Novel derivatives of dicarboxylic acid having pharmaceutical properties
09/05/2001EP1129064A1 Transfection reagents
09/05/2001CN1311773A Neuropeptide Y5 receptor antagonists
09/05/2001CN1311772A New 3-aryl-2-hydoxy-propionic acid derivative I
09/05/2001CN1311769A New 3-aryl-2-hydroxypropionic acid derivative III
09/04/2001US6284796 Naphthamidine compounds
09/04/2001US6284767 Retroviral protease inhibiting compounds
08/2001
08/29/2001EP1127869A1 Novel compounds and medicinal use thereof
08/29/2001EP0889877B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS
08/29/2001EP0809624B1 Alkylcarboxy amino acids-modulators of the kainate receptor
08/29/2001EP0804410B1 Method of preparing retroviral protease inhibitor intermediates
08/28/2001US6281170 Surface tension reduction with N,N,N'-trialkkyl ureas
08/28/2001CA2017252C Retroviral protease inhibiting compounds
08/23/2001WO2001008633A3 An improved form of form I celiprolol hydrochloride
08/23/2001US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/23/2001DE10005631A1 Arginin-Mimetika als Faktor X¶a¶-Inhibitoren Arginine mimetics as inhibitors of factor X¶a¶
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/21/2001US6277880 Chemical compounds
08/21/2001US6277624 Mutants which produce a potentiator of Bacillus pesticidal activity
08/16/2001WO2001058859A1 ARGININE MIMETICS AS FACTOR Xa INHIBITORS
08/16/2001WO2001058855A1 Use of androgen receptor suppressors
08/16/2001WO2001058854A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions
08/16/2001WO2001009096A3 Potassium channel openers
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 99